Pretražite po imenu i prezimenu autora, mentora, urednika, prevoditelja

Napredna pretraga

Pregled bibliografske jedinice broj: 416463

Pregnancy outcome after gestational exposure to the new macrolides : a prospective multi-center observational study


Bar-Oz, B.; Diav-Citrin, O.; Shechtman, S.; Tellem, R.; Arnon, J.; Francetić, Igor; Berkovitch, M.; Ornoy, A.
Pregnancy outcome after gestational exposure to the new macrolides : a prospective multi-center observational study // European Journal of Obstetrics & Gynecology and Reproductive Biology, 141 (2008), 1; 31-34 doi:10.1016/j.ejogrb.2008.07.008 (međunarodna recenzija, članak, znanstveni)


CROSBI ID: 416463 Za ispravke kontaktirajte CROSBI podršku putem web obrasca

Naslov
Pregnancy outcome after gestational exposure to the new macrolides : a prospective multi-center observational study

Autori
Bar-Oz, B. ; Diav-Citrin, O. ; Shechtman, S. ; Tellem, R. ; Arnon, J. ; Francetić, Igor ; Berkovitch, M. ; Ornoy, A.

Izvornik
European Journal of Obstetrics & Gynecology and Reproductive Biology (0301-2115) 141 (2008), 1; 31-34

Vrsta, podvrsta i kategorija rada
Radovi u časopisima, članak, znanstveni

Ključne riječi
pregnancy; macrolides; exposure; azithromyci; clarithromyci; roxithromycin; congenital malformations

Sažetak
To determine whether the use of the new macrolides (azithromycin, clarithromycin, roxithromycin) during the first trimester of pregnancy is associated with an increased risk of major malformations. In a prospective multi-center study, pregnancy outcome was compared between pregnant women exposed to one of the new macrolides during the first trimester of pregnancy and two comparison groups one exposed to other antibiotics and the other to other non-teratogenic medications. All women enrolled in the study called one of the three participating teratogen information services (TIS). Group 1 macrolides (n=161), group 2 other antibiotics (n=213) and group 3 non-teratogens (n=740). A total of 161 women exposed to the new macrolides (118 were exposed in the first trimester of pregnancy) and 953 from a comparison groups were followed up. The rate of major malformations in the study group was 4.1% compared to 2.1% in the other antibiotics exposed group (OR=1.41, 95% CI 0.47-4.23) and 3.0% in the non-teratogens exposed group. The rate of elective terminations of pregnancy was significantly higher in the exposed group in compare to both comparison groups. Our study, although relatively small sized, suggests that the use of the new macrolides during the first trimester of pregnancy does not represent an increased risk for congenital malformations strong enough for an induced abortion after such an exposure. Elective terminations of pregnancy because of early exposure to these medications should be reconsidered.

Izvorni jezik
Engleski

Znanstvena područja
Kliničke medicinske znanosti



POVEZANOST RADA


Projekti:
108-1080114-0016 - Modifikacija antimikrobne terapije i rezistencija patogenih mikroorganizama (Francetić, Igor, MZOS ) ( CroRIS)

Ustanove:
Medicinski fakultet, Zagreb

Profili:

Avatar Url Igor Francetić (autor)

Poveznice na cjeloviti tekst rada:

doi www.sciencedirect.com

Citiraj ovu publikaciju:

Bar-Oz, B.; Diav-Citrin, O.; Shechtman, S.; Tellem, R.; Arnon, J.; Francetić, Igor; Berkovitch, M.; Ornoy, A.
Pregnancy outcome after gestational exposure to the new macrolides : a prospective multi-center observational study // European Journal of Obstetrics & Gynecology and Reproductive Biology, 141 (2008), 1; 31-34 doi:10.1016/j.ejogrb.2008.07.008 (međunarodna recenzija, članak, znanstveni)
Bar-Oz, B., Diav-Citrin, O., Shechtman, S., Tellem, R., Arnon, J., Francetić, I., Berkovitch, M. & Ornoy, A. (2008) Pregnancy outcome after gestational exposure to the new macrolides : a prospective multi-center observational study. European Journal of Obstetrics & Gynecology and Reproductive Biology, 141 (1), 31-34 doi:10.1016/j.ejogrb.2008.07.008.
@article{article, author = {Bar-Oz, B. and Diav-Citrin, O. and Shechtman, S. and Tellem, R. and Arnon, J. and Franceti\'{c}, Igor and Berkovitch, M. and Ornoy, A.}, year = {2008}, pages = {31-34}, DOI = {10.1016/j.ejogrb.2008.07.008}, keywords = {pregnancy, macrolides, exposure, azithromyci, clarithromyci, roxithromycin, congenital malformations}, journal = {European Journal of Obstetrics and Gynecology and Reproductive Biology}, doi = {10.1016/j.ejogrb.2008.07.008}, volume = {141}, number = {1}, issn = {0301-2115}, title = {Pregnancy outcome after gestational exposure to the new macrolides : a prospective multi-center observational study}, keyword = {pregnancy, macrolides, exposure, azithromyci, clarithromyci, roxithromycin, congenital malformations} }
@article{article, author = {Bar-Oz, B. and Diav-Citrin, O. and Shechtman, S. and Tellem, R. and Arnon, J. and Franceti\'{c}, Igor and Berkovitch, M. and Ornoy, A.}, year = {2008}, pages = {31-34}, DOI = {10.1016/j.ejogrb.2008.07.008}, keywords = {pregnancy, macrolides, exposure, azithromyci, clarithromyci, roxithromycin, congenital malformations}, journal = {European Journal of Obstetrics and Gynecology and Reproductive Biology}, doi = {10.1016/j.ejogrb.2008.07.008}, volume = {141}, number = {1}, issn = {0301-2115}, title = {Pregnancy outcome after gestational exposure to the new macrolides : a prospective multi-center observational study}, keyword = {pregnancy, macrolides, exposure, azithromyci, clarithromyci, roxithromycin, congenital malformations} }

Časopis indeksira:


  • Current Contents Connect (CCC)
  • Web of Science Core Collection (WoSCC)
    • Science Citation Index Expanded (SCI-EXP)
    • SCI-EXP, SSCI i/ili A&HCI
  • Scopus
  • MEDLINE


Uključenost u ostale bibliografske baze podataka::


  • EMBASE (Excerpta Medica)


Citati:





    Contrast
    Increase Font
    Decrease Font
    Dyslexic Font